# AFib 2gether™ — Shared Decision Making

> Shared decision-making tool for atrial fibrillation patients and clinicians regarding stroke risk. (iPhone/iPad app by Pfizer Inc.)

- Source: https://appshunter.io/ios/app/afib-2gether/id1410849532 (this page in markdown: same URL + `.md`)
- Developer: [Pfizer Inc](https://appshunter.io/developer/400502925)
- Category: Medical, Health & Fitness
- Price: Free
- Rating: 3.00/5 from 3 App Store ratings
- Age rating: 17+
- Requires: iOS 16.0 · 19 MB
- Languages: American English
- Released: 2018-08-05
- Data updated: 2026-06-10
- Monetization: free
- User reviews in markdown: https://appshunter.io/ios/app/afib-2gether/id1410849532/reviews.md

## What is AFib 2gether™?

ion : AFib 2gether™ is a shared decision-making mobile platform that may be helpful to both patients and clinicians. AFib 2gether™ helps you build your understanding of stroke risk due to diagnosis of atrial fibrillation, which is a type of irregular heartbeat, not caused by heart valve problem. The goal of the app is to help you have an informed discussion with your health care provider.

For atrial fibrillation patients and caregivers:
You will answer questions which will help you and your clinicians determine your risk of stroke due to atrial fibrillation by providing a personalized risk score calculation. You will also be able to prioritize questions of importance about your atrial fibrillation and stroke risk for discussion with your healthcare provider.

Utilizing the Resources section within the app will help you learn about atrial fibrillation and the risks associated with this condition. You will also have the opportunity to understand the terminology of your condition; view videos that help you understand the condition, and access links to other helpful sites.

For atrial fibrillation providers:
AFib 2gether™ helps support a shared decision making conversation for patients who are diagnosed with atrial
fibrillation not caused by a heart valve problem. In 2016, the ACC/AHA/HRS published quality metrics which highlight shared decision making in atrial fibrillation. The app will assist the patient-provider interaction and help facilitate a discussion about stroke risk due to atrial fibrillation. 

Intended for U.S. audiences only.
The health information contained herein is provided for educational purposes only and not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

Provided by Pfizer

## Key features

- Personalized stroke risk score calculation
- Prioritize questions for healthcare provider
- Educational resources on atrial fibrillation
- Videos and links for condition understanding
- Facilitates shared decision-making conversations


## Frequently asked questions about AFib 2gether™

### What is AFib 2gether™ used for?

AFib 2gether™ is a shared decision-making platform designed to help patients and clinicians understand stroke risk associated with atrial fibrillation. It facilitates informed discussions about the condition and personalized risk assessment.

### Who is AFib 2gether™ intended for?

The app is intended for patients diagnosed with atrial fibrillation (not caused by a heart valve problem) and their caregivers, as well as healthcare providers who treat these patients. It is specifically for U.S. audiences.

### How does AFib 2gether™ help patients?

Patients can answer questions to receive a personalized stroke risk score and prioritize important questions to discuss with their healthcare provider. The app also offers educational resources, videos, and links to help them understand atrial fibrillation.

### How does AFib 2gether™ support healthcare providers?

For providers, AFib 2gether™ assists in shared decision-making conversations with patients diagnosed with atrial fibrillation. It helps facilitate discussions about stroke risk and aligns with quality metrics for shared decision-making in AFib care.

### Is AFib 2gether™ free to use?

Yes, AFib 2gether™ is available for free. It does not have in-app purchases or advertisements, offering a completely free experience for users.

### What is the age rating for AFib 2gether™?

AFib 2gether™ has an age rating of 17+. This indicates that the content is suitable for mature teenagers and adults, likely due to the medical nature of the information presented.

### On which devices can I use AFib 2gether™?

AFib 2gether™ is supported on both iPhone and iPad devices. This allows for access on a range of Apple mobile devices.

### How often is AFib 2gether™ updated?

The app was last updated on February 13, 2024, with version 2.0.3. This indicates a recent update, suggesting ongoing maintenance and potential improvements.

## Version history (last 5 releases)

### 2.0.3 — 2024-02-13

Updated bugs and backend functioning

### 2.0.2 — 2023-07-10

Updated screen shots.

### 2.0.1 — 2023-04-24

SDK Upgrade for Compatibility changes

### 2.0.0 — 2023-01-10

• Completely Redesigned Look & Feel
- Enhanced Use of Pictures and Graphics
• Refreshed Educational Content
- Websites and Videos from HRS, AHA, etc.
- NEW Patient Videos about AFib
• Improved Patient/Provider Experience

### 1.0.6 — 2021-10-04

Maintenance and bug fixes changes.

## More apps by Pfizer Inc

- [HemMobile](https://appshunter.io/ios/app/hemmobile/id570014269)
- [AcroTracker](https://appshunter.io/ios/app/acrotracker/id652123144)
- [Impala Kit Verify](https://appshunter.io/ios/app/impala-kit-verify/id1073923357)
- [Pfizer PRISM](https://appshunter.io/ios/app/pfizer-prism/id1121288274)
- [Travel Smart - Pfizer Travel](https://appshunter.io/ios/app/travel-smart-pfizer-travel/id1146917076)
- [Shipment Notification](https://appshunter.io/ios/app/shipment-notification/id1185634161)

All apps by Pfizer Inc: https://appshunter.io/developer/400502925

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-10.*
